Metraipolis › archive › dc_bbbdaa1bd0cf

Comparative safety and effectiveness of apixaban and rivaroxaban for treatment of cancer-associated venous thromboembolism: A retrospective cohort study — Europe PMC PMID:41004533

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41004533
DOI: 10.1371/journal.pmed.1004754
License (as archived): solo-consultazione
Archived: 2026-11-09T17:55:12.872Z
SHA-256 of the archived text: 0eecc6cc42954ae49d2025425ccb74d89f0639c5b392af53588ff5b63499e97e
Stable URL of this page: https://metraipolis.com/documento/dc_bbbdaa1bd0cf

How to cite

Comparative safety and effectiveness of apixaban and rivaroxaban for treatment of cancer-associated venous thromboembolism: A retrospective cohort study — Europe PMC PMID:41004533 — Europe PMC (en), https://europepmc.org/article/MED/41004533 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bbbdaa1bd0cf (Metraipolis archive dc_bbbdaa1bd0cf, sha256 0eecc6cc42954ae49d2025425ccb74d89f0639c5b392af53588ff5b63499e97e)

BibTeX

@misc{dcbbbdaa1bd0cf,
  title = {Comparative safety and effectiveness of apixaban and rivaroxaban for treatment of cancer-associated venous thromboembolism: A retrospective cohort study — Europe PMC PMID:41004533},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41004533},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bbbdaa1bd0cf; sha256 0eecc6cc42954ae49d2025425ccb74d89f0639c5b392af53588ff5b63499e97e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41004533. Agents can read the archived copy with the MCP tool read_document.